Last reviewed · How we verify
NCT05977959: HSRC
Optimizing the Impact of the Healthy School Recognized Campus Program on Youth's CVD Risk Factors
NA trial testing Mentoring Program in Cardiovascular Diseases in 159 participants. Completed in 30 June 2025.
30 June 2025
Quick facts
| Lead sponsor | Texas A&M University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | factorial |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 159 |
| Start date | 13 September 2023 |
| Primary completion | 30 June 2025 |
| Estimated completion | 30 June 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Mentoring Program
- Enhanced Resources
- Enhanced Engagement
Conditions studied
- Cardiovascular Diseases — all drugs for Cardiovascular Diseases →
- Physical Activity — all drugs for Physical Activity →
- Nutrition — all drugs for Nutrition →
Sponsor
Texas A&M University
Who can join
Adults 10 to 14, any sex, with Cardiovascular Diseases or Physical Activity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Healthy School Recognized Campus is a Texas A\&M AgriLife Extension initiative that supports the delivery of school-based physical activity and nutrition programs for diverse youth across Texas. The purpose of this study is to improve the delivery of these programs and optimize the effect they have on youth's cardiovascular risk factors.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Design and methodology of a cluster randomized factorial trial to optimize implementation strategies for the Healthy School Recognized Campus initiative.
Szeszulski J, Schaefers A, De Mello GT, Gardner J, et al · · 2025 · cited 1× · PMID 41246086 · DOI 10.3389/fpubh.2025.1652485
Verify or expand the search:
- PubMed search for NCT05977959
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Mentoring Program
Trials testing the same drug.
- NCT05300295 — Mentorship Program for Individuals With Autism Spectrum Disorder (ASD) · NA · completed
Other recruiting trials for Cardiovascular Diseases
Currently open trials in the same condition.
- NCT07442578 — Impact of Exercise Intensity on Cardiac Health in Young Adult Survivors of Childhood Cancer: The PULSE Trial · NA · active not recruiting
- NCT07426263 — Effectiveness of a Therapeutic Education Program on Female Sexuality in Women Attending Cardiac Rehabilitation. · NA · active not recruiting
- NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
- NCT07324278 — Hybrid Stroke Rehab With Mirror Priming · NA · recruiting
- NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting
Other Texas A&M University trials
Trials by the same sponsor.
- NCT07079995 — Healthy School Recognized Campus: A Hybrid Type 2 Implementation-Effectiveness Trial · NA · recruiting
- NCT06950775 — The Neighborhood & Health Study · recruiting
- NCT06890689 — Effectiveness of Scaling and Root Planing in Deeper Pockets · active not recruiting
- NCT06797089 — Does myTAP Oral Appliance Therapy Including a Mouth Shield Lessen Periodontitis in Mouth-Breathers Who Snore? · NA · completed
- NCT05959434 — Integration of Cognitive Processing Therapy and Relapse Prevention for Alcohol Use Disorder and PTSD · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05977959 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Texas A&M University
- Last refreshed: 12 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05977959.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing